{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:29:03Z","timestamp":1789082943490,"version":"build-2803163510"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"10","funder":[{"DOI":"10.13039\/501100003493","name":"Hertie Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["Ri2175\/1-1"],"award-info":[{"award-number":["Ri2175\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1093\/brain\/awx196","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T19:15:15Z","timestamp":1500059715000},"page":"2623-2638","source":"Crossref","is-referenced-by-count":42,"title":["Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell death"],"prefix":"10.1093","volume":"140","author":[{"given":"Anna-Luisa","family":"Thiepold","sequence":"first","affiliation":[{"name":"Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site Frankfurt\/Mainz, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja I","family":"Lorenz","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site Frankfurt\/Mainz, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Foltyn","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site Frankfurt\/Mainz, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L","family":"Engel","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site Frankfurt\/Mainz, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Div\u00e9","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site Frankfurt\/Mainz, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Urban","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site Frankfurt\/Mainz, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Heller","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site Frankfurt\/Mainz, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Bruns","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site Frankfurt\/Mainz, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and University of T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Dr\u00f6se","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick N","family":"Harter","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), Partner Site Frankfurt\/Mainz, Frankfurt am Main, Germany"},{"name":"Institute of Neurology (Edinger-Institute), University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Mittelbronn","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), Partner Site Frankfurt\/Mainz, Frankfurt am Main, Germany"},{"name":"Institute of Neurology (Edinger-Institute), University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim P","family":"Steinbach","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site Frankfurt\/Mainz, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W","family":"Ronellenfitsch","sequence":"additional","affiliation":[{"name":"Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site Frankfurt\/Mainz, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,8,11]]},"reference":[{"key":"key\n\t\t\t\t20180328143520_awx196-B1","doi-asserted-by":"crossref","first-page":"14534","DOI":"10.1038\/srep14534","article-title":"PAK2 is an effector of TSC1\/2 signaling independent of mTOR and a potential therapeutic target for tuberous sclerosis complex","volume":"5","author":"Alves","year":"2015","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20180328143520_awx196-B2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1212\/WNL.0000000000000594","article-title":"Sustained focal antitumor activity of bevacizumab in recurrent glioblastoma","volume":"83","author":"Bahr","year":"2014","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180328143520_awx196-B3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328143520_awx196-B4","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/cncr.28732","article-title":"Mutant IDH1 inhibits PI3K\/Akt signaling in human glioma","volume":"120","author":"Birner","year":"2014","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180328143520_awx196-B5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1535-6108(03)00336-2","article-title":"Antiangiogenic therapy and tumor progression","volume":"5","author":"Blagosklonny","year":"2004","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20180328143520_awx196-B6","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1256804","article-title":"Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex","volume":"18","author":"Brugarolas","year":"2004","journal-title":"Genes Dev"},{"key":"key\n\t\t\t\t20180328143520_awx196-B7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nature06322","article-title":"mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex","volume":"450","author":"Cunningham","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180328143520_awx196-B8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/neuonc\/nop027","article-title":"Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice","volume":"12","author":"de Groot","year":"2010","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t20180328143520_awx196-B9","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1158\/1078-0432.CCR-11-2390","article-title":"Microarray analysis verifies two distinct phenotypes of glioblastomas resistant to antiangiogenic therapy","volume":"18","author":"DeLay","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20180328143520_awx196-B10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/bjc.1997.102","article-title":"Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells","volume":"75","author":"Di Monaco","year":"1997","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20180328143520_awx196-B11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","article-title":"TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1","volume":"47","author":"Dibble","year":"2012","journal-title":"Mol Cell"},{"key":"key\n\t\t\t\t20180328143520_awx196-B12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Duvel","year":"2010","journal-title":"Mol Cell"},{"key":"key\n\t\t\t\t20180328143520_awx196-B13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/bj1380425","article-title":"Regulation of the pentose phosphate cycle","volume":"138","author":"Eggleston","year":"1974","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t20180328143520_awx196-B14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-014-1352-5","article-title":"Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas","volume":"129","author":"Fack","year":"2015","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328143520_awx196-B15","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world's knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20180328143520_awx196-B16","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1101\/gad.912401","article-title":"Hierarchical phosphorylation of the translation inhibitor 4E-BP1","volume":"15","author":"Gingras","year":"2001","journal-title":"Genes Dev"},{"key":"key\n\t\t\t\t20180328143520_awx196-B17","first-page":"1114","article-title":"An improved tissue culture assay. III. Alternate methods for measuring cell growth","volume":"20","author":"Grady","year":"1960","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180328143520_awx196-B18","doi-asserted-by":"crossref","first-page":"e0127123","DOI":"10.1371\/journal.pone.0127123","article-title":"Immunohistochemical assessment of phosphorylated mTORC1-pathway proteins in human brain tumors","volume":"10","author":"Harter","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328143520_awx196-B19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.cmet.2012.08.009","article-title":"Complexome profiling identifies TMEM126B as a component of the mitochondrial complex I assembly complex","volume":"16","author":"Heide","year":"2012","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20180328143520_awx196-B20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"Hockel","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328143520_awx196-B21","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1021\/ac2031699","article-title":"Simultaneous quantification of eleven thiopurine nucleotides by liquid chromatography-tandem mass spectrometry","volume":"84","author":"Hofmann","year":"2012","journal-title":"Anal Chem"},{"key":"key\n\t\t\t\t20180328143520_awx196-B22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/bit.21747","article-title":"Identification of metabolic fluxes in hepatic cells from transient 13C-labeling experiments: part I. Experimental observations","volume":"100","author":"Hofmann","year":"2008","journal-title":"Biotechnol Bioeng"},{"key":"key\n\t\t\t\t20180328143520_awx196-B23","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1158\/0008-5472.CAN-11-3831","article-title":"Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma","volume":"72","author":"Hu","year":"2012","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180328143520_awx196-B24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t20180328143520_awx196-B25","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa066838","article-title":"Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma","volume":"356","author":"Hudes","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328143520_awx196-B26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1750-3639.1999.tb00536.x","article-title":"Frequent co-alterations of TP53, p16\/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines","volume":"9","author":"Ishii","year":"1999","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20180328143520_awx196-B27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.1239947","article-title":"Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma","volume":"343","author":"Johnson","year":"2014","journal-title":"Science"},{"key":"key\n\t\t\t\t20180328143520_awx196-B28","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1073\/pnas.1014480108","article-title":"Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma","volume":"108","author":"Keunen","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180328143520_awx196-B29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10059-013-0138-2","article-title":"Nutrient regulation of the mTOR complex 1 signaling pathway","volume":"35","author":"Kim","year":"2013","journal-title":"Mol Cells"},{"key":"key\n\t\t\t\t20180328143520_awx196-B30","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328143520_awx196-B31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328143520_awx196-B32","doi-asserted-by":"crossref","first-page":"427518","DOI":"10.1155\/2015\/427518","article-title":"EGFR amplification and glioblastoma stem-like cells","volume":"2015","author":"Liffers","year":"2015","journal-title":"Stem Cells Int"},{"key":"key\n\t\t\t\t20180328143520_awx196-B33","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/jm101520v","article-title":"Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer","volume":"54","author":"Liu","year":"2011","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20180328143520_awx196-B34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cub.2005.02.053","article-title":"Rheb binds and regulates the mTOR kinase","volume":"15","author":"Long","year":"2005","journal-title":"Curr Biol"},{"key":"key\n\t\t\t\t20180328143520_awx196-B35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ymben.2009.06.001","article-title":"Quantification of statin effects on hepatic cholesterol synthesis by transient C-flux analysis","volume":"11","author":"Maier","year":"2009","journal-title":"Metab Eng"},{"key":"key\n\t\t\t\t20180328143520_awx196-B36","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1752-0509-4-54","article-title":"Dynamics and control of the central carbon metabolism in hepatoma cells","volume":"4","author":"Maier","year":"2010","journal-title":"BMC Syst Biol"},{"key":"key\n\t\t\t\t20180328143520_awx196-B37","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"Network","year":"2008","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180328143520_awx196-B38","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1158\/0008-5472.CAN-04-1337","article-title":"Genetic pathways to glioblastoma: a population-based study","volume":"64","author":"Ohgaki","year":"2004","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180328143520_awx196-B39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","article-title":"The tuberous sclerosis complex","volume":"1184","author":"Orlova","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20180328143520_awx196-B40","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/1535-7163.MCT-09-0274","article-title":"Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition","volume":"8","author":"Rapisarda","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"key\n\t\t\t\t20180328143520_awx196-B41","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1200\/JCO.2010.29.2029","article-title":"Bevacizumab-induced diffusion restriction in patients with glioma: tumor progression or surrogate marker of hypoxia?","volume":"28","author":"Rieger","year":"2010","journal-title":"J Clin Oncol"},{"issue":"Pt 6","key":"key\n\t\t\t\t20180328143520_awx196-B42","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/brain\/awp093","article-title":"Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death","volume":"132","author":"Ronellenfitsch","year":"2009","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180328143520_awx196-B43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11523-010-0154-5","article-title":"Epidermal growth factor receptor and mammalian target of rapamycin as therapeutic targets in malignant glioma: current clinical status and perspectives","volume":"5","author":"Ronellenfitsch","year":"2010","journal-title":"Target Oncol"},{"key":"key\n\t\t\t\t20180328143520_awx196-B44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s002620050355","article-title":"Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics","volume":"44","author":"Roth","year":"1997","journal-title":"Cancer Immunol Immunother"},{"key":"key\n\t\t\t\t20180328143520_awx196-B45","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2015.61.5005","article-title":"Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: retrospective analysis of the AVAglio trial","volume":"33","author":"Sandmann","year":"2015","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180328143520_awx196-B46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.15252\/emmm.201505505","article-title":"Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma","volume":"8","author":"Scholz","year":"2015","journal-title":"EMBO Mol Med"},{"key":"key\n\t\t\t\t20180328143520_awx196-B47","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1158\/0008-5472.CAN-03-3775","article-title":"Inhibition of epidermal growth factor receptor signaling protects human malignant glioma cells from hypoxia-induced cell death","volume":"64","author":"Steinbach","year":"2004","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180328143520_awx196-B48","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.cdd.4401252","article-title":"Hypoxia-induced cell death in human malignant glioma cells: energy deprivation promotes decoupling of mitochondrial cytochrome c release from caspase processing and necrotic cell death","volume":"10","author":"Steinbach","year":"2003","journal-title":"Cell Death Differ"},{"key":"key\n\t\t\t\t20180328143520_awx196-B49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00688585","article-title":"Characterization of four human malignant glioma cell lines","volume":"66","author":"Studer","year":"1985","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20180328143520_awx196-B50","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328143520_awx196-B51","doi-asserted-by":"crossref","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"key\n\t\t\t\t20180328143520_awx196-B52","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1038\/onc.2011.530","article-title":"Synthesis of cytochrome C oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell death","volume":"31","author":"Wanka","year":"2012","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20180328143520_awx196-B53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/neuonc\/nos273","article-title":"Standards of care for treatment of recurrent glioblastoma\u2014are we there yet?","volume":"15","author":"Weller","year":"2013","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t20180328143520_awx196-B54","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/ijc.28576","article-title":"Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy","volume":"134","author":"Weller","year":"2014","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180328143520_awx196-B55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01476489","article-title":"Karyotype analyses of 20 human glioma cell lines","volume":"126","author":"Westphal","year":"1994","journal-title":"Acta Neurochir"},{"key":"key\n\t\t\t\t20180328143520_awx196-B56","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1038\/sj.onc.1207198","article-title":"CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death","volume":"22","author":"Wischhusen","year":"2003","journal-title":"Oncogene"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/140\/10\/2623\/23003001\/awx196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T00:36:57Z","timestamp":1659227817000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/140\/10\/2623\/4080837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,11]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,8,11]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awx196","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10]]},"published":{"date-parts":[[2017,8,11]]}}}